In animal studies, the protein-based contrast agent called hProCA32.Collagen2, under development by InLighta BioSciences, allowed for identification of lung tumors and metastases as small as 1 millimeter, according to a report in Science Advances.
News
New dye for MRI exams detects lung cancer earlier
September 17, 2026In animal studies, the protein-based contrast agent called hProCA32.Collagen2, under development by InLighta BioSciences, allowed for identification of lung tumors and metastases as small as 1 millimeter, according to a report in Science Advances.